{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:03:03Z","timestamp":1787947383806,"version":"build-2784847793"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.transci.2026.104396","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:32:16Z","timestamp":1769844736000},"page":"104396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Apheresis in Ethiopia: Availability, challenges, and opportunities"],"prefix":"10.1016","volume":"65","author":[{"given":"Ashenafi Tazebew","family":"Amare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104396_bib1","series-title":"Donor Selection: Guidelines on Assessing Donor Suitability for Blood Donation","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.transci.2026.104396_bib2","series-title":"Global Status Report on Blood Safety and Availability","author":"World Health Organization","year":"2021"},{"issue":"2","key":"10.1016\/j.transci.2026.104396_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the american society for apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2026.104396_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000485721","article-title":"Apheresis for kidney disease","volume":"196","author":"Furuichi","year":"2018","journal-title":"Contrib Nephrol"},{"issue":"5","key":"10.1016\/j.transci.2026.104396_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.transci.2017.08.014","article-title":"LDL apheresis in Japan","volume":"56","author":"Makino","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2026.104396_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosissup.2019.08.028","article-title":"Apheresis as an emerging treatment option in severe early onset preeclampsia","volume":"40","author":"Contini","year":"2019","journal-title":"Atheroscler Suppl"},{"issue":"3","key":"10.1016\/j.transci.2026.104396_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/ACI.0000000000000366","article-title":"Apheresis in food allergies","volume":"17","author":"Dahdah","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.transci.2026.104396_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/1744-9987.12499","article-title":"Therapeutic Apheresis in Immunologic Renal and Neurological Diseases","volume":"21","author":"Bambauer","year":"2017","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2026.104396_bib9","first-page":"380","article-title":"Seeing is believing: A review of apheresis therapy in the treatment of ophthalmologic disease","volume":"33","author":"Graham","year":"2018"},{"issue":"4","key":"10.1016\/j.transci.2026.104396_bib10","article-title":"The status of apheresis and component therapy in Africa: gaps and prospects","volume":"61","author":"Balogun","year":"2022","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2026.104396_bib11","first-page":"91","article-title":"Therapeutic PLasma Exchange in Africa: experience and limitations","volume":"46","author":"Afolabi","year":"2023","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.transci.2026.104396_bib12","article-title":"Donor apheresis in Africa: current status and challenges","author":"Crookes","year":"2013","journal-title":"Presente Int Soc Apher (ISFA)"},{"issue":"3","key":"10.1016\/j.transci.2026.104396_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103167","article-title":"Taking therapeutic apheresis services to patients in South Africa: an eight-year review of the SANBS mobile therapeutic apheresis service (2013\u20132020)","volume":"60","author":"Poole","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.transci.2026.104396_bib14","first-page":"533","article-title":"Namibia\u2019s transition from whole-blood-derived pooled platelets to single-donor apheresis platelets","volume":"55","author":"Pitman","year":"2015","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.transci.2026.104396_bib15","first-page":"287","article-title":"Benefits and challenges of starting a therapeutic apheresis service in a resource-constrained setting","volume":"29","author":"Arogundade","year":"2014","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.transci.2026.104396_bib16","first-page":"1756","article-title":"Barriers to accessing therapeutic apheresis in Sub-Saharan Africa: a scoping review","volume":"13","author":"Osei","year":"2024","journal-title":"Afr J Lab Med"},{"key":"10.1016\/j.transci.2026.104396_bib17","series-title":"Impact of COVID-19 on Blood Supply and Demand in the WHO African Region","author":"World Health Organization Regional Office for Africa (WHO AFRO)","year":"2021"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:18:18Z","timestamp":1782199098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1473050226000285"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104396","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apheresis in Ethiopia: Availability, challenges, and opportunities","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104396"}}